Cancer Care in Transgender Youth Patients: Things to Consider

If transgender youth and adults are undergoing (or planning) gender-affirming surgery, taking masculinizing or feminizing hormones, and they have cancer, these treatments can have implications for their care. Cancer treatments in turn can have implications for their gender-affirming care. Oncologists should take gender identity into account in making decisions about cancer treatment. This starts with … Read more

Innovative Gene Editing Could Cure Severe Congenital Neutropenia

Fionn Mulrooney, a cheerful 11-month-old, in Plymouth, Massachusetts, has no idea he has a life-threatening genetic disease. Nor does he seem fazed by the daily subcutaneous injections his parents have learned how to give him. And little does he know that cells from his bone marrow are helping scientists develop an innovative gene-editing approach that … Read more

‘They’re Always There’: Emotional Support for Childhood Cancer Patients and Parents at Dana-Farber

When Samantha Price’s four-year-old daughter, Shelby, was diagnosed with acute lymphoblastic leukemia (T-ALL) in October 2019, Price had so many questions about what the future held for both of them. What would the highs and lows of treatment look and feel like for Shelby, and how could she best care for her daughter throughout the … Read more

Neuroblastoma Patient Exudes Untold Strength

Call it mother’s intuition, but leading up to her daughter’s cancer diagnosis, Erica Jensen knew something wasn’t right. At just 10 months, Charlee had started walking, and since taking her first steps the excited toddler was constantly exploring the world around her. Then, at around 15 months, something changed. It wasn’t obvious at first — … Read more

Medulloblastoma Patient Ready to Be a Positive Light for Others

Erica Domeier thought she would be preparing for her upcoming graduation and making plans for her final summer before college in June 2014. Instead, the 17-year-old was in the hospital, having recently been diagnosed with brain cancer. It was the beginning of what would be a difficult road for Domeier. But today, because of her … Read more

Diving Into Ependymomas, Hard-to-Treat Pediatric Brain Tumors

Ependymomas are some of the most difficult-to-treat brain tumors. Mariella Filbin, MD, PhD, a neuro-oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, is driven by a desire to find new therapies for these pediatric brain tumors. At the core of her work is an effort to uncover the events that shape tumor development. Defining how … Read more

Young Dancer Stays on Toes During Rare Kidney Cancer Treatment

Carly Tobin loves dancing for the fun and freedom it provides. During treatment for a rare pediatric kidney cancer known as Wilms tumor, the pre-teen’s passion also proved a vital source of strength. Diagnosed in early June 2019, Carly — now 11 and cancer-free — underwent surgery, radiation, and chemotherapy at Dana-Farber/Boston Children’s Cancer and … Read more

Childhood Cancer Patients and the Coronavirus: Common Questions Answered

How does a person get coronavirus?  Coronavirus is spread primarily by exposure to respiratory droplets that are generated when an infected individual coughs or sneezes. If these droplets come in contact with the eyes, nose, or mouth of another person, infection can develop.  Infected droplets can remain active on surfaces for some time. This can happen, for … Read more

Could Leukemia Be Stopped Before It Starts? Researchers Aim to Find Out

Acute myeloid leukemia (AML), a blood cancer affecting both adults and children, requires more than one genetic “hit” to develop. As we age, many of us acquire a mutation that enables certain of our blood cells to multiply faster than others, forming their own distinct population. This first hit, known as “clonal hematopoiesis of indeterminate … Read more

A Big Step Toward Curbing Graft-vs.-Host Disease After Bone Marrow Transplant

This post originally appeared on Discoveries, the blog of Boston Children’s Hospital. A drug used for rheumatoid arthritis has moved a step closer to U.S. Food and Drug Administration (FDA) approval for a desperately needed new use. The drug, abatacept, has gained FDA breakthrough therapy designation for preventing acute, severe graft-versus-host disease (GVHD) in patients receiving bone … Read more

Bone Cancer in Children: What are the Latest Treatment Options?

Medically reviewed by Katherine A. Janeway, MD Cancer affecting the bones may be primary (a cancer that develops within the bone) or metastatic (spreading to bones from elsewhere in the body). Many primary bone tumors are benign (noncancerous), but others are malignant. Treatment options for bone tumors include surgery, chemotherapy, radiation therapy, cryosurgery (freezing cancer … Read more

Drug Shows Promise as First Definitive Treatment for Rare Anemia

Medically reviewed by Rachael Grace, MD In the mid-1960s, David G. Nathan, MD, president emeritus of Dana-Farber and, at that time, a hematologist at Boston Children’s Hospital, published some of the first reports on a rare, inherited type of anemia caused by the breakdown of red blood cells because of a lack of a key … Read more